Inventor · disambiguated record
Michael C. Kiefer
Also filed as: KIEFER MICHAEL · KIEFER MICHAEL C
44 granted patents·17 pending applications·624 citations·filing 1990–2024
98Inventor score
Top patents by PatentIndex Score
61 records- 0198US7081340B2Gene expression profiling in biopsied tumor tissuesGENOMIC HEALTH INC·Filed 2003·Granted Jul 25, 2006·199 cites·7 claims
- 0294US7888019B2Genes involved estrogen metabolismGENOMIC HEALTH INC·Filed 2007·Granted Feb 15, 2011·20 cites·8 claims
- 0394US7858304B2Gene expression profiling in biopsied tumor tissuesGENOMIC HEALTH INC·Filed 2006·Granted Dec 28, 2010·18 cites·18 claims
- 0493US8071286B2Gene expression profiling in biopsied tumor tissuesBAKER JOFFRE B·Filed 2006·Granted Dec 6, 2011·15 cites·18 claims
- 0593US7838224B2Gene expression profiling in biopsied tumor tissuesGENOMIC HEALTH INC·Filed 2006·Granted Nov 23, 2010·15 cites·19 claims
- 0692US7767391B2Use of intronic RNA to measure gene expressionGENOMIC HEALTH INC·Filed 2004·Granted Aug 3, 2010·62 cites·7 claims
- 0790US8808994B2Genes involved in estrogen metabolismKIEFER MICHAEL C·Filed 2010·Granted Aug 19, 2014·8 cites·20 claims
- 0889US8906625B2Genes involved in estrogen metabolismKIEFER MICHAEL C·Filed 2010·Granted Dec 9, 2014·7 cites·19 claims
- 0986US12412642B2Method to use gene expression to determine likelihood of clinical outcome of renal cancerGENOMIC HEALTH INC·Filed 2023·Granted Sep 9, 2025·0 cites·20 claims
- 1086US10260104B2Method for using gene expression to determine prognosis of prostate cancerGENOMIC HEALTH INC·Filed 2015·Granted Apr 16, 2019·2 cites·11 claims
- 1186US9551034B2Method to use gene expression to determine likelihood of clinical outcome of renal cancerCOWENS WAYNE·Filed 2011·Granted Jan 24, 2017·5 cites·12 claims
- 1285US2025129432A1Method for Using Gene Expression to Determine Prognosis of Prostate CancerMDXHEALTH SA·Filed 2024·Application pending·0 cites
- 1384US10227621B2Method for preparing an aqueous acrylamide solution having a low acrylic acid concentrationBASF SE·Filed 2015·Granted Mar 12, 2019·3 cites·29 claims
- 1478US5620867ABone morphogenetic protein expression and DNACHIRON CORP·Filed 1993·Granted Apr 15, 1997·39 cites·18 claims
- 1574US11776664B2Method to use gene expression to determine likelihood of clinical outcome of renal cancerGENOMIC HEALTH INC·Filed 2020·Granted Oct 3, 2023·0 cites·20 claims
- 1674US6485922B1Methods for detecting compounds which modulate the activity of an LPA receptorATAIRGIN TECHNOLOGIES INC·Filed 1998·Granted Nov 26, 2002·28 cites·4 claims
- 1773US6906029B2Insulin-like growth factor binding protein (IGFBP-5)CHIRON CORP·Filed 2002·Granted Jun 14, 2005·1 cites·19 claims
- 1872US2019249260A1Method for Using Gene Expression to Determine Prognosis of Prostate CancerGENOMIC HEALTH INC·Filed 2019·Application pending·0 cites
- 1970US6903195B1Methods and compositions for detecting CDN apoptosis-modulating proteinsTANOX INC·Filed 2000·Granted Jun 7, 2005·2 cites·4 claims
- 2070US6436639B1Bak promoter expression systemTANOX INC·Filed 1998·Granted Aug 20, 2002·25 cites·20 claims
- 2169US2020255911A1Method for Using Gene Expression to Determine Prognosis of Prostate CancerGENOMIC HEALTH INC·Filed 2020·Application pending·0 cites
- 2267US5652210ASoluble splice variant of the Fas (APO-1) antigen, FasΔTMLXR BIOTECHNOLOGY INC·Filed 1995·Granted Jul 29, 1997·23 cites·6 claims
- 2366US5863756ACompositions and methods for PACE 4 and 4.1 gene and polypeptides in cellsCHIRON CORP·Filed 1994·Granted Jan 26, 1999·19 cites·42 claims
- 2464US10892038B2Method to use gene expression to determine likelihood of clinical outcome of renal cancerGENOMIC HEALTH INC·Filed 2016·Granted Jan 12, 2021·0 cites·22 claims
- 2564US6586395B1Apoptosis-modulating proteinsTANOX INC·Filed 1995·Granted Jul 1, 2003·11 cites·6 claims
- 2664US6369029B1Method of stimulating osteogenesis using a c-terminally truncated insulin-like growth factor binding protein-5 (IGFBP-5)CHIRON CORP·Filed 1995·Granted Apr 9, 2002·18 cites·15 claims
- 2763US5663070ARecombinant production of a soluble splice variant of the Fas (Apo-1) antigen, fas TMLXR BIOTECHNOLOGY INC·Filed 1993·Granted Sep 2, 1997·15 cites·8 claims
- 2863US2010209920A1Gene Expression Profiling in Biopsied Tumor TissuesBAKER JOFFRE B·Filed 2009·Application pending·0 cites
- 2963US2016259881A1Methods of incorporation of transcript chromosomal locus information for identification of biomarkers of disease recurrence riskGENOMIC HEALTH INC·Filed 2014·Application pending·0 cites
- 3063US2020105367A1Methods of Incorporation of Transcript Chromosomal Locus Information for Identification of Biomarkers of Disease Recurrence RiskGENOMIC HEALTH INC·Filed 2019·Application pending·0 cites
- 3162US2005136058A1Insulin-like growth factor binding protein (IGFBP-5)CHIRON CORP·Filed 2005·Application pending·0 cites
- 3262US2007117748A1Novel apoptosis-modulating proteins, dna encoding the proteins and methods of use thereofTANOX INC·Filed 2006·Application pending·0 cites
- 3361US5770443AApoptosis-modulating proteins, DNA encoding the proteins and methods of use thereofLXR BIOTECHNOLOGY INC·Filed 1995·Granted Jun 23, 1998·9 cites·30 claims
- 3460US7754418B2Methods and compositions for detecting CDN apoptosis-modulating proteinsGENENTECH INC·Filed 2005·Granted Jul 13, 2010·0 cites·2 claims
- 3559US2008182255A1Gene Expression Profiling in Biopsied Tumor TissuesBAKER JOFFRE B·Filed 2007·Application pending·0 cites
- 3657US10241114B2Gene expression profiling in biopsied tumor tissuesBAKER JOFFRE B·Filed 2006·Granted Mar 26, 2019·0 cites·18 claims
- 3757US8329398B2Universal amplification of fragmented RNAKIEFER MICHAEL C·Filed 2007·Granted Dec 11, 2012·0 cites·10 claims
- 3857US2012028264A1Method for using gene expression to determine prognosis of prostate cancerSHAK STEVEN·Filed 2011·Application pending·0 cites
- 3957US2005095634A1qRT-PCR assay system for gene expression profilingGENOMIC HEALTH INC·Filed 2004·Application pending·0 cites
- 4056US7888038B2Bak binding protein, DNA encoding the protein, and methods of use thereofGENENTECH INC·Filed 2006·Granted Feb 15, 2011·0 cites·15 claims
- 4156US6391588B1Nucleic acid molecules encoding truncated insulin-like growth factor binding-5 proteinsCHIRON CORP·Filed 1995·Granted May 21, 2002·11 cites·16 claims
- 4255US7108989B2Apoptosis-modulating proteins, DNA encoding the proteins and methods of use thereofTANOX INC·Filed 2002·Granted Sep 19, 2006·0 cites·28 claims
- 4355US6025465AInsulin-like growth factor binding protein (IGFBP-6)CHIRON CORP·Filed 1997·Granted Feb 15, 2000·11 cites·4 claims
- 4455US2003124660A1Bak promoter expression systemTANOX INC·Filed 2002·Application pending·0 cites
- 4555US2005196782A1Universal amplification of fragmented RNAFiled 2004·Application pending·0 cites
- 4654US6015687AApoptosis-modulating proteins, DNA encoding the proteins and methods of use thereofLXR BIOTECHNOLOGY INC·Filed 1995·Granted Jan 18, 2000·6 cites·1 claims
- 4754US2012142099A1Novel bak binding protein, dna encoding the protein, and methods of use thereofKIEFER MICHAEL C·Filed 2011·Application pending·0 cites
- 4854US2007238638A1Bak promoter expression systemTANOX INC·Filed 2006·Application pending·0 cites
- 4953US5212074AGenetic material encoding new insulin-like growth factor binding protein igfbp-6CHIRON CORP·Filed 1990·Granted May 18, 1993·16 cites·11 claims
- 5050US6489294B1Truncated insulin-like growth factor binding protein-5 having mitogenic activityCHIRON CORP·Filed 1995·Granted Dec 3, 2002·7 cites·9 claims
Showing the top 50 of 61 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →